Answers are grounded in this paper and cite their sources.
Amid growing concerns regarding antibiotic-resistant infections, nanoparticles have attracted significant interest as alternative antimicrobial agents in nanobiotechnology. Zirconium oxide nanoparticles ( ZrO 2 NPs), also known as zirconia, have emerged as promising candidates owing to their unique physicochemical properties. This study evaluated the antibacterial and genotoxic effects of ZrO 2 NPs on Escherichia coli . For this purpose, bacterial cultures were exposed to ZrO 2 NPs at concentrations of 100, 250, and 350 μ g /mL, and growth was monitored 2, 4, 6, 8, and 24 h post-exposure. Significant growth inhibition was observed at 250 μ g /mL and 350 μ g /mL, particularly after 8 h of exposure. However, genomic analysis using RAPD markers revealed no significant DNA alterations at any of the concentrations tested. These findings suggest that ZrO 2 NPs, particularly at higher concentrations, exhibit effective antibacterial activity without inducing detectable genotoxic effects, underscoring their potential as safe and efficient antimicrobial agents.
No takes yet. Share an insight, caveat, or question.
Rashidi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: